Systematic Characterization and Biological Functions of Non-coding RNAs in Glioblastoma

Overview

Journal Cell Prolif

Date 2022 Dec 2

PMID 36457281

Authors

Lirui Dai

Wulong Liang

Zimin Shi

Xiang Li

Shaolong Zhou

Weihua Hu

Zhuo Yang

Xinjun Wang

Affiliations

Soon will be listed here.

Abstract

Glioblastoma multiforme (GBM) is the most malignant and aggressive type of glioma. Non-coding RNAs (ncRNAs) are RNAs that do not encode proteins but widely exist in eukaryotic cells. The common characteristics of these RNAs are that they can all be transcribed from the genome without being translated into proteins, thus performing biological functions, particularly microRNAs (miRNAs), long non-coding RNAs (lncRNAs) and circular RNAs. Studies have found that ncRNAs are associated with the occurrence and development of GBM, and there is a complex regulatory network among ncRNAs, which can regulate cell proliferation, migration, apoptosis and differentiation, thus provide a basis for the development of highly specific diagnostic tools and therapeutic strategies in the future. The present review aimed to comprehensively describe the biogenesis, general features and functions of regulatory ncRNAs in GBM, and to interpret the potential biological functions of these ncRNAs in GBM as well as their impact on clinical diagnosis, treatment and prognosis and discusses the potential mechanisms of these RNA subtypes leading to cancer in order to contribute to the better design of personalized GBM therapies in the future.

Citing Articles

The Emerging Role of IGF2BP2 in Cancer Therapy Resistance: From Molecular Mechanism to Future Potential.

Li D, Hu S, Ye J, Zhai C, Liu J, Wang Z Int J Mol Sci. 2024; 25(22).

PMID: 39596216 PMC: 11595103. DOI: 10.3390/ijms252212150.

Research progress of drug resistance mechanism of temozolomide in the treatment of glioblastoma.

Wu H, Gao W, Chen P, Wei Y, Zhao H, Wang F Heliyon. 2024; 10(21):e39984.

PMID: 39568843 PMC: 11577240. DOI: 10.1016/j.heliyon.2024.e39984.

Unlocking the Potential of Circulating miRNAs as Biomarkers in Glioblastoma.

Suvarnapathaki S, Serrano-Farias A, Dudley J, Bettegowda C, Rincon-Torroella J Life (Basel). 2024; 14(10).

PMID: 39459612 PMC: 11509808. DOI: 10.3390/life14101312.

Glucose metabolism in glioma: an emerging sight with ncRNAs.

Rong J, Wang Q, Li T, Qian J, Cheng J Cancer Cell Int. 2024; 24(1):316.

PMID: 39272133 PMC: 11395608. DOI: 10.1186/s12935-024-03499-8.

CircVPS8 promotes the malignant phenotype and inhibits ferroptosis of glioma stem cells by acting as a scaffold for MKRN1, SOX15 and HNF4A.

Hu J, Li X, Xu K, Chen J, Zong S, Zhang H Oncogene. 2024; 43(36):2679-2695.

PMID: 39098847 DOI: 10.1038/s41388-024-03116-y.

References

Lv T, Jin Y, Miao Y, Xu T, Jia F, Feng H . LncRNA PVT1 promotes tumorigenesis of glioblastoma by recruiting COPS5 to deubiquitinate and stabilize TRIM24. Mol Ther Nucleic Acids. 2021; 27:109-121. PMC: 8649109. DOI: 10.1016/j.omtn.2021.11.012. View

Wang X, Cao Q, Shi Y, Wu X, Mi Y, Liu K . Identification of low-dose radiation-induced exosomal circ-METRN and miR-4709-3p/GRB14/PDGFRα pathway as a key regulatory mechanism in Glioblastoma progression and radioresistance: Functional validation and clinical theranostic significance. Int J Biol Sci. 2021; 17(4):1061-1078. PMC: 8040305. DOI: 10.7150/ijbs.57168. View

Zhu F, Cheng C, Qin H, Wang H, Yu H . A novel circular RNA circENTPD7 contributes to glioblastoma progression by targeting ROS1. Cancer Cell Int. 2020; 20:118. PMC: 7147020. DOI: 10.1186/s12935-020-01208-9. View

Zhang J, Wang P, Yan Y, Li Y, Guan M, Yu J . IL‑33 enhances glioma cell migration and invasion by upregulation of MMP2 and MMP9 via the ST2-NF-κB pathway. Oncol Rep. 2017; 38(4):2033-2042. PMC: 5652951. DOI: 10.3892/or.2017.5926. View

Chen L, Li Z, Hu S, Deng Q, Hao P, Guo S . Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2. Cancer Chemother Pharmacol. 2022; 89(2):217-229. DOI: 10.1007/s00280-021-04392-1. View

van Zonneveld A, Kolling M, Bijkerk R, Lorenzen J . Circular RNAs in kidney disease and cancer. Nat Rev Nephrol. 2021; 17(12):814-826. DOI: 10.1038/s41581-021-00465-9. View

Wang D, Chen Q, Liu J, Liao Y, Jiang Q . Silencing of lncRNA CHRM3-AS2 Expression Exerts Anti-Tumour Effects Against Glioma Targeting microRNA-370-5p/KLF4. Front Oncol. 2022; 12:856381. PMC: 8962832. DOI: 10.3389/fonc.2022.856381. View

Gheidari F, Arefian E, Jamshidi Adegani F, Kalhori M, Seyedjafari E, Kabiri M . miR-424 induces apoptosis in glioblastoma cells and targets AKT1 and RAF1 oncogenes from the ERBB signaling pathway. Eur J Pharmacol. 2021; 906:174273. DOI: 10.1016/j.ejphar.2021.174273. View

Wang Y, Shan A, Zhou Z, Li W, Xie L, Du B . LncRNA TCONS_00004099-derived microRNA regulates oncogenesis through PTPRF in gliomas. Ann Transl Med. 2021; 9(12):1023. PMC: 8267291. DOI: 10.21037/atm-21-2442. View

10.

Schafer A, Evers L, Meier L, Schlomann U, Bopp M, Dreizner G . The Metalloprotease-Disintegrin ADAM8 Alters the Tumor Suppressor miR-181a-5p Expression Profile in Glioblastoma Thereby Contributing to Its Aggressiveness. Front Oncol. 2022; 12:826273. PMC: 8964949. DOI: 10.3389/fonc.2022.826273. View

11.

Huang C, Liao X, Jin H, Xie F, Zheng F, Li J . MEG3, as a Competing Endogenous RNA, Binds with miR-27a to Promote PHLPP2 Protein Translation and Impairs Bladder Cancer Invasion. Mol Ther Nucleic Acids. 2019; 16:51-62. PMC: 6396102. DOI: 10.1016/j.omtn.2019.01.014. View

12.

Tang G, Luo L, Zhang J, Zhai D, Huang D, Yin J . lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-κB signaling in glioblastoma. Cancer Lett. 2020; 498:152-164. DOI: 10.1016/j.canlet.2020.10.047. View

13.

Cai H, Yu Y, Ni X, Li C, Hu Y, Wang J . LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis. Cell Death Dis. 2020; 11(12):1032. PMC: 7710718. DOI: 10.1038/s41419-020-03247-6. View

14.

Li J, Li Q, Lin L, Wang R, Chen L, Du W . Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT). BMC Neurol. 2018; 18(1):133. PMC: 6117922. DOI: 10.1186/s12883-018-1139-8. View

15.

Gao M, Wang X, Han D, Lu E, Zhang J, Zhang C . A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme. Front Genet. 2021; 11:604655. PMC: 7874158. DOI: 10.3389/fgene.2020.604655. View

16.

Lu Y, Guo G, Hong R, Chen X, Sun Y, Liu F . LncRNA HAS2-AS1 Promotes Glioblastoma Proliferation by Sponging miR-137. Front Oncol. 2021; 11:634893. PMC: 8173206. DOI: 10.3389/fonc.2021.634893. View

17.

Zhao C, Wang X, Zhang Y, Zhou Y, Yin Q, Yao W . MicroRNA-424 inhibits cell migration, invasion and epithelial-mesenchymal transition in human glioma by targeting KIF23 and functions as a novel prognostic predictor. Eur Rev Med Pharmacol Sci. 2018; 22(19):6369-6378. DOI: 10.26355/eurrev_201810_16049. View

18.

Pang B, Quan F, Ping Y, Hu J, Lan Y, Pang L . Dissecting the Invasion-Associated Long Non-coding RNAs Using Single-Cell RNA-Seq Data of Glioblastoma. Front Genet. 2021; 11:633455. PMC: 7831882. DOI: 10.3389/fgene.2020.633455. View

19.

Li W, Liu J, Ji L, Tang Y, Qin J, Zhao H . MiR-674-5p Suppresses the Proliferation and Migration of Glioma Cells by Targeting Cul4b. Neurochem Res. 2021; 47(3):679-691. DOI: 10.1007/s11064-021-03476-x. View

20.

Huang K, Yue X, Zheng Y, Zhang Z, Cheng M, Li L . Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma. Front Oncol. 2021; 11:726745. PMC: 8446619. DOI: 10.3389/fonc.2021.726745. View